US Tobacco 21 Policies and Potential Mortality Reductions by State

Area of Science:

• Public Health
• Health Policy
• Epidemiology

Background:

• Tobacco 21 (T21) policies raise the minimum legal age for tobacco sales to 21.
• These policies aim to reduce smoking initiation and prevalence, particularly among young adults.
• The impact of T21 policies on smoking-related mortality can vary due to state-specific factors.

Purpose of the Study:

• To quantify the potential reduction in smoking-attributable mortality across all 50 US states and Washington, DC, due to Tobacco 21 policies.
• To model the long-term impact of T21 policies on premature deaths and life-years gained from 2005 to 2100.
• To assess the influence of varying T21 policy coverage and enforcement levels on mortality outcomes.

Main Methods:

• Utilized the Cancer Intervention Surveillance and Modeling Network (CISNET) Tobacco Control Policy Model.
• Integrated state-specific data on smoking initiation, cessation, and mortality rates by demographics and birth cohort.
• Incorporated comprehensive data on T21 policy coverage (state and local) from 2005-2024 and applied quasi-experimental effect estimates.

Main Results:

• Comprehensive T21 policy enforcement nationwide could avert up to 526,000 premature deaths and gain 13.3 million life-years by 2100.
• Early adoption in states like California showed substantial mortality reductions (e.g., >27,000 deaths averted).
• States lacking comprehensive T21 policies, like Wisconsin, could prevent significant deaths (up to 10,000) with federal T21 enforcement.

Conclusions:

• Early and comprehensive implementation of Tobacco 21 policies maximizes reductions in premature mortality.
• Significant variations exist in T21 policy strength and enforcement across US states.
• Enforcement of the federal T21 law is critical for states lacking their own T21 cigarette policies to achieve maximum public health benefits.